Submission Details
| 510(k) Number | K192050 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 31, 2019 |
| Decision Date | September 27, 2019 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K192050 is an FDA 510(k) clearance for the ETEST Eravacycline (ERV) (0.002 ? 32 ?g/mL), a Manual Antimicrobial Susceptibility Test Systems (Class II — Special Controls, product code JWY), submitted by Biomerieux S.A. (Marcy L'Etoile, FR). The FDA issued a Cleared decision on September 27, 2019, 58 days after receiving the submission on July 31, 2019. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.1640.
| 510(k) Number | K192050 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 31, 2019 |
| Decision Date | September 27, 2019 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | JWY — Manual Antimicrobial Susceptibility Test Systems |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.1640 |